A European perspective on the Dialysis Access Consortium (DAC) study regarding the effects of clopidogrel on early failure of arteriovenous fistulas for hemodialysis.
Chemla
E S
ES
Renal Transplant Department, St Georges Healthcare NHS Trust, London, UK. eric.chemla@stgeorges.nhs.uk
Morsy
M
M
D001166:Arteriovenous Shunt, Surgical / Q000009:adverse effects*; D000077144:Clopidogrel; D005060:Europe; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D007391:International Cooperation; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D006435:Renal Dialysis; D012107:Research Design; D013927:Thrombosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017211:Treatment Failure; D014654:Vascular Patency / Q000187:drug effects
D005343:Fibrinolytic Agents; D000077144:Clopidogrel; D013988:Ticlopidine